Skip to main
  1. Stocks
  2. CVS Health
  3. Forecast
CVS

CVS Health (CVS) Stock Forecast & Price Target

CVS Health (CVS) Analyst Ratings

Based on 17 analyst ratings
Buy
Strong Buy 29%
Buy 71%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

CVS Health is viewed positively because its integrated model across retail pharmacy, PBM, health insurance, specialty, and primary care creates multiple earnings engines and natural offsets, helping the enterprise absorb segment-level pressure while still compounding value. The company’s scale is compelling, with around 9,000 stores, about 2 billion adjusted claims annually, and roughly 26 million medical members, while recent results showed broad-based growth, nearly $4.7 billion of quarterly operating cash flow, and an increased full-year outlook to at least $15.5 billion. The outlook also reflects improving Medicare Advantage economics, durable pharmacy profit growth, and an HSS EBIT floor for FY27, with buybacks resuming and the planned early 2028 separation seen as a way to sharpen focus and reduce regulatory overhang.

Bears say

CVS Health is facing a fundamentally pressured outlook because its model is exposed to multiple overlapping margin headwinds: PBM rebate retention is expected to fall below recent trends, 340B rules and litigation could trim economics by roughly $90MM annually, and elevated utilization is pressuring Aetna’s medical benefit ratio. Its retail pharmacy business also remains burdened by declining reimbursement, fixed-cost leverage, and consumer softness, while channel competition from digital players continues to erode growth and profitability. The planned separation in 1H'28 adds strategic uncertainty just as these problems persist, raising doubts that the combined business can fully preserve today’s competitive advantages and flexibility.

CVS Health (CVS) has been analyzed by 17 analysts, with a consensus rating of Buy. 29% of analysts recommend a Strong Buy, 71% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of CVS Health and is not a guaranteed prediction by Public.com or investment advice.

CVS Health (CVS) Analyst Forecast & Price Prediction

Get the latest CVS Health (CVS) stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in CVS Health (CVS)

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About CVS Health (CVS) Forecast

Analysts have given CVS Health (CVS) a Buy based on their latest research and market trends.

According to 17 analysts, CVS Health (CVS) has a Buy consensus rating as of Nov 16, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $110.18, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $110.18, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

CVS Health (CVS)


CVS Health (CVS) Analyst Forecast & Price Prediction

Get the latest CVS Health (CVS) stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in CVS Health (CVS)

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.
Uncover CVS stock data and trends